Ä¢¹½AV

The news:. A new report reviewed by STAT reveals that Pfizer and Eli Lilly pay their telehealth provider partners upwards of a few million dollars. Our take: Drugmakers in the D2C telehealth market likely won’t be too worried about the report’s findings. It will be difficult for regulators to prove that a pharma company’s payment to a telehealth partner is directly tied to prescription volume. Drug brands will need to boost awareness of their D2C offerings to justify the price they pay telehealth firms, however.

Home Depot made a bid for GMS, a building products and tool supplier for both consumers and contractors, per The Wall Street Journal. Our take: Home Depot sees a significant opportunity to consolidate the fragmented construction supply and tool market—and it's moving at a moment when the US housing shortfall could drive sustained demand for new construction and renovation.